Acne Vulgaris - 475 Studies Found Completed : A Study of Different Use Regimens Using Two Acne Treatments : Acne Vulgaris : 2009-05-20 : Drug: benzoyl peroxide wash 5% Completed : A Study to Evaluate the Safety and Efficacy of Omiganan (CLS001) Topical Gel Versus Vehicle in Female Subjects With Moderate to Severe Acne Vulgaris : Acne Vulgaris : 2015-10-02 : Drug: Omiganan (CLS001) Topical Gel Drug: Completed : To Study Generic Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel (Glenmark Generics, Ltd) in the Treatment of Acne Vulgaris. : Acne Vulgaris : 2015-06-04 : Drug: Clindamycin 1%/Benzoyl Peroxide 5% Topical Gel Withdrawn : Clinical Trial Phase III to Assess the Non-inferiority of Dalap Duo® Product Compared to Epiduo® in the Treatment of Acne Vulgaris : Acne Vulgaris : 2015-01-15 : Drug: Adapalene and Benzoyl peroxide Dalap Duo® Completed : A Phase 4, Single-Blind, Randomized, Study to Compare the Tolerability and Efficacy of 0.1% Tazorac Cream When Used in Combination With Either Duac Gel or Acanya Gel for the Treatment of Facial Acne Vulgaris : Acne Vulgaris : 2009-11-19 : Drug: Clindamycin 1%/Benzoyl Peroxide 5% and 0.1% tazarotene Completed : A Efficacy and Safety of Duac™Compared With Clindamycin Phosphate Gel in the Treatment of Mild to Moderate Acne Vulgaris : Acne Vulgaris : 2013-04-05 : Drug: Duac™Once Daily Gel Completed : A Study of a New Drug Treatment for Acne : Acne Vulgaris : 2011-03-30 : Drug: 1.2% JNJ 10229570-AAA 1. Terminated : Study Comparing Acne in Patients Taking Oral Minocycline to Patients Taking Minocycline Plus Topical Tretinoin : Acne Vulgaris : 2005-10-16 : Drug: Minocycline 100 mg capsu Completed : Two-week Study to Compare the Tolerance and Irritation Potential of Two Combination Topical Gel Acne Medications : Acne Vulgaris : 2009-06-21 : Drug: Clindamycin and benzoyl peroxide Completed : Evaluation of Quality of Life, Efficacy, and Tolerance of Duac® Gel Compared to Differin® Gel in the Treatment of Acne : Acne Vulgaris : 2008-12-10 : Drug: Duac Gel Duac® Gel <<< Previous | Next >>>
